BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

被引：0
|
作者：
Scaccabarozzi, L. [1 ]
Asano, E. [1 ]
Guimaraes, T. B. [1 ]
机构：
[1] Janssen, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1038
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY20
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
  • [21] Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies
    van der Horst-Bruinsma, Irene E.
    Zack, Debra Jeske
    Szumski, Annette
    Koenig, Andrew S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (07) : 1221 - 1224
  • [22] ANALYSIS OF THE BUDGET IMPACT OF SECUKINUMAB USE VERSUS ANTI-TNF AGENTS IN ANKYLOSING SPONDYLITIS PATIENTS
    Romero Prada, M. E.
    Roa, Cardenas N. C.
    Serrano, G. Y.
    Huerfano, L. M.
    VALUE IN HEALTH, 2017, 20 (09) : A937 - A937
  • [23] BUDGET IMPACT ANALYSIS: WOULD THE BRAZILIAN PUBLIC HEALTH SYSTEM INCREASE, BY MEANS OF TRANSPLANTS, THE COST OF TREATMENT OF CHRONIC TERMINAL KIDNEY DISEASE?
    Alvares, J.
    Falleiros, D. R.
    Barbosa, M. M.
    Almeida, A. M.
    Araujo, V. E.
    Guerra Junior, A. A.
    Cherchiglia, M. L.
    Acurcio, F. D. A.
    VALUE IN HEALTH, 2013, 16 (07) : A665 - A665
  • [24] BUDGET IMPACT ANALYSIS OF EMICIZUMAB PROPHYLAXIS FOR HEAMOPHILIA A PATIENTS WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
    Souza, P.
    Puopolo, G. R.
    Leme-Souza, R.
    VALUE IN HEALTH, 2019, 22 : S847 - S847
  • [25] BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUES FOR TYPE 1 DIABETES: THE CASE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
    Laranjeira, F.
    Mega, T. P.
    Lima, L. P. S.
    Salomon, F. C. R.
    Petramale, C.
    VALUE IN HEALTH, 2014, 17 (03) : A243 - A243
  • [26] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A BUDGET IMPACT ANALYSIS UNDER THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Oliveira, L. E.
    Caires, A. L.
    Abreu, G. R.
    Nita, M. E.
    VALUE IN HEALTH, 2017, 20 (05) : A156 - A156
  • [27] Incorporation of a DIRECT ACTING ANTIVIRAL Treatment for HEPATITIS C in the Brazilian Public Health System
    Lemos, Mayra Braga
    da Costa, Milene Rangel
    de Almeida, Rosimary Terezinha
    XXVI BRAZILIAN CONGRESS ON BIOMEDICAL ENGINEERING, CBEB 2018, VOL 1, 2019, 70 (01): : 779 - 782
  • [28] THE IMPACT OF BIOLOGIC THERAPY VERSUS CONVENTIONAL TREATMENT ON THE COSTS OF ANKYLOSING SPONDYLITIS CHRONIC COMPLICATIONS UNDER THE PERSPECTIVE OF BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Menezes, F. G.
    Chibana, V
    Tolentino, A. C.
    Reis, F. H.
    VALUE IN HEALTH, 2015, 18 (07) : A641 - A641
  • [29] Cost impact for the treatment of urinary lithiasis in the Brazilian Public Health System
    Glina, Sidney
    EINSTEIN-SAO PAULO, 2011, 9 (04): : VII - VIII
  • [30] COST-MINIMIZATION ANALYSIS OF BIOLOGICAL DRUGS IN THE TREATMENT OF SPONDYLOARTHRITIS (PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS) UNDER THE BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE
    Scaccabarozzi, L.
    Asano, E.
    Monteiro, A. C.
    VALUE IN HEALTH, 2016, 19 (03) : A249 - A249
12345